RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+5.37%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.38B
AUM Growth
+$2.38B
(+1.8%)
Cap. Flow
-$42.6M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
48.22%
Holding
72
New
8
Increased
21
Reduced
14
Closed
10
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$81.3M |
| 2 |
NRG Energy
NRG
|
$24.3M |
| 3 |
QuidelOrtho
QDEL
|
$21.7M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$18.4M |
| 5 |
Heron Therapeutics
HRTX
|
$15.4M |
Top Sells
| 1 |
Vistra
VST
|
$73.4M |
| 2 |
LendingClub
LC
|
$51.8M |
| 3 |
Scorpio Tankers
STNG
|
$48.8M |
| 4 |
Fluor
FLR
|
$38M |
| 5 |
Par Pacific Holdings
PARR
|
$25.9M |
Sector Composition
| 1 | Healthcare | 39.91% |
| 2 | Energy | 13.82% |
| 3 | Industrials | 11.46% |
| 4 | Financials | 8.86% |
| 5 | Utilities | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $194M | 7.27% | 19,000,000 +281,638 | +2% | +$2.87M |
|
2
Golar LNG
GLNG
$4.48B
| $158M | 5.92% | 6,506,757 +50,000 | +0.8% | +$1.21M |
|
3
Viatris
VTRS
$12.3B
| $131M | 4.9% | 13,250,000 +1,300,000 | +11% | +$12.8M |
|
|
4
Roivant Sciences
ROIV
$8.15B
| $123M | 4.6% | 10,500,000 +6,963,562 | +197% | +$81.3M |
|
5
BGC Group
BGC
$4.65B
| $106M | 3.96% | 20,000,000 | – | – |
|
6
Mr. Cooper
COOP
$12.1B
| $105M | 3.95% | 1,965,173 | – | – |
|
7
Cameco
CCJ
$33.7B
| $100M | 3.75% | 2,523,540 -171,464 | -6% | -$6.8M |
|
|
8
Fluor
FLR
$6.63B
| $87.3M | 3.28% | 2,379,657 -1,034,692 | -30% | -$38M |
|
9
AAR Corp
AIR
$2.72B
| $73.1M | 2.74% | 1,228,422 | – | – |
|
10
Collegium Pharmaceutical
COLL
$1.22B
| $71M | 2.66% | 3,175,000 -250,000 | -7% | -$5.59M |
|
|
11
Par Pacific Holdings
PARR
$1.76B
| $70.9M | 2.66% | 1,972,181 -722,029 | -27% | -$25.9M |
|
12
Hertz
HTZ
$1.78B
| $63.3M | 2.37% | 5,165,254 -555,636 | -10% | -$6.81M |
|
13
Mativ Holdings
MATV
$687M
| $57M | 2.14% | 4,000,000 +562,422 | +16% | +$8.02M |
|
14
ReNew
RNW
$2.76B
| $53.7M | 2.02% | 9,897,426 +1,731,521 | +21% | +$9.4M |
|
15
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $53.5M | 2.01% | 3,077,449 -300,715 | -9% | -$5.22M |
|
|
16
NRG Energy
NRG
$28.2B
| $50.8M | 1.9% | 1,318,020 +629,993 | +92% | +$24.3M |
|
17
Adeia
ADEA
$1.64B
| $49.6M | 1.86% | 4,640,009 +47,448 | +1% | +$507K |
|
18
ANI Pharmaceuticals
ANIP
$2.03B
| $49.2M | 1.84% | 847,011 | – | – |
|
19
Koppers
KOP
$571M
| $45M | 1.69% | 1,138,592 +73,151 | +7% | +$2.89M |
|
20
Orthofix Medical
OFIX
$592M
| $44.2M | 1.66% | 3,434,665 +1,042,253 | +44% | +$13.4M |
|
21
Dole
DOLE
$1.4B
| $43.3M | 1.63% | 3,742,152 +104,474 | +3% | +$1.21M |
|
|
PTVE
22
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $40.7M | 1.52% | 5,000,000 +184,217 | +4% | +$1.5M |
|
23
Xperi
XPER
$278M
| $39.9M | 1.5% | 4,043,744 +200,000 | +5% | +$1.97M |
|
|
HOLI
24
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $38.5M | 1.44% | 1,941,237 | – | – |
|
25
TransAlta
TAC
$3.65B
| $38.3M | 1.44% | 4,404,844 +978,354 | +29% | +$8.51M |
|